2024-03-28T13:46:13Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_36D87E9EDAD0
2024-03-23T02:11:23Z
openaire
documents
urnserval
serval:BIB_36D87E9EDAD0
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.
10.1093/annonc/mdp496
000272924300016
19889608
Larbouret
C.
author
Robert
B.
author
Bascoul-Mollevi
C.
author
Penault-Llorca
F.
author
Ho-Pun-Cheung
A.
author
Morisseau
S.
author
Navarro-Teulon
I.
author
Mach
J.P.
author
Pèlegrin
A.
author
Azria
D.
author
article
2010
Annals of Oncology
1569-8041[electronic]
journal
21
1
98-103
EGFR
gemcitabine
HER2
monoclonal antibodies
pancreatic carcinoma
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_36D87E9EDAD0
https://serval.unil.ch/resource/serval:BIB_36D87E9EDAD0.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_36D87E9EDAD06
Copying allowed only for non-profit organizations